Patent · US Expired

Methods of treating obsessive-compulsive disorder

US7026332B2 · kind B2 · utility

1Cited by

3References

3Claims

0Family size

Assignee

Indevus Pharmaceuticals, Inc. · US

Inventors

Cathryn Clary · New York, US
Jeroen Van Beek · Hoboken, BE
Perry S. Eisman · Southampton, US
Sean Donevan · Dexter, US
Atul Pande · East Lyme, US
Richard Kavoussi · Ann Arbor, US
Lyou-Fu Ma · Ann Arbor, US

Key dates

Filing date	Apr 25, 2002
Grant date	Apr 11, 2006
Priority date	—
Expiry date	Apr 25, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of treating obsessive-compulsive disorder comprising administering 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.